
Yet we are led to believe that the LGBT community is somehow more dangerous. None can claim to be morally superior, given their answer to abuse is to cover it up. All claim to be the superior form of Christianity, and all cherry-pick the Bible with abandon. Roman Catholic abuse scandals are not uncommon, and it would not surprise me if similar tales of abuse exist within Orthodox and Protestant Churches.
#Liberas treatment series#
Bruce Gerencser’s site has a series called ‘Black Collar Crime’, which talks of the alleged failings – usually very serious – of the IFB Churches. I’m very aware of the culture of pederasty that exists in predominantly Muslim nations.Ĭherry-picking is something a lot of extremists have in common. Not to mention that this is ONE sect in the broader Christian umbrella* as we see near daily reporting of other clergy/pastors being arrested for sexual abuse and/or child porn.īut ‘drag shows’ are the problem? Transgenderism is the problem? We have some serious moral rot in our society….but the self-proclaimed exemplars are focusing on the wrong problems. Given the previous reporting of similar abuses in other Diocese, if we presume even 10% of the criminal and immoral acts were committed over the same time frame (likely a low estimate). That’s only ONE Diocese out of 194 in the United States alone. Another priest was allowed to feign hepatitis treatment and make other excuses to avoid facing abuse allegations. One deacon admitted to molesting over 100 children. Mark Parish in Catonsville, which had 11 abusers living and working there between 19. Some parishes, schools and congregations had more than one abuser at the same time - including St. The report paints a damning picture of the archdiocese, which is the oldest Roman Catholic diocese in the country and spans much of Maryland. Libertas study NRL001 faecal incontinence α1-adrenoceptor agonist.Ĭolorectal Disease © 2014 The Association of Coloproctology of Great Britain and Ireland.Report details ‘staggering’ church sex abuse in MarylandīALTIMORE (AP) - More than 150 Catholic priests and others associated with the Archdiocese of Baltimore sexually abused over 600 children and often escaped accountability, according to a long-awaited state report released Wednesday that revealed the scope of abuse spanning 80 years and accused church leaders of decades of coverups.

Innovative strategies were developed to meet the challenge of recruiting patients for this study, for example, media advertising, posters and mailshots as allowed by each study centre. Furthermore, this is the first time the impact of NRL001 on assessments of QoL, health outcomes and patient satisfaction will be assessed. This is the first randomised controlled study to investigate the efficacy and safety of a selective α1 -adrenoceptor agonist for the treatment of faecal incontinence. Overall patient satisfaction with the treatment will also be evaluated. Secondary outcomes include measures of efficacy of NRL001 compared with placebo following 8 weeks treatment safety and tolerability evaluation of plasma pharmacokinetics establishment of any pharmacokinetic/pharmacodynamic relationship to adverse events dose-response relationship the efficacy of NRL001 therapy at 4 and 8 weeks assessed by the Vaizey score and QoL using the Faecal Incontinence Quality of Life and the EQ-5D-5L Healthcare Questionnaires following 4 and 8 weeks NRL001 therapy.

The primary objective of Libertas is to assess the impact of once daily administration of NRL001 on the severity and frequency of incontinence episodes as assessed by the Wexner score at 4 weeks, compared with placebo. Patients suffering with faecal incontinence were randomised into four groups (approximately 110 each) to receive once daily self-administered doses of NRL001 (5, 7.5 or 10 mg or placebo in a suppository formulation) for 8 weeks.

Patient recruitment took place across 55 study centres in Europe.

Libertas is a multicentre, Phase II, double-blind, randomised, placebo-controlled, parallel group study. Libertas, a robustly designed study will investigate the efficacy and safety of NRL001 (1R,2S-methoxamine), an α1 -adrenoceptor agonist, in the treatment of faecal incontinence. There have been few well-designed, placebo-controlled clinical trials of treatment for faecal incontinence and little clinical evidence is available to inform the most appropriate management strategies. Faecal incontinence is an underreported health problem as the social isolation and stigma that patients experience makes it difficult for sufferers to discuss their condition with a physician. Associated social isolation and subsequent depression can have devastating effects on quality of life (QoL). Faecal incontinence affects up to 8% of adults.
